当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:262.30亿  总市值:262.30亿
流通股本:88.32亿   总股本:88.32亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.72亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1818182.59万元,未分配利润911915.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2871931.96万元,负债1053749.37万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,387,806,236.797,187,510,832.555,926,520,025.823,921,052,446.51
营业总成本1,212,017,795.367,030,846,930.025,726,755,746.573,858,427,658.1
其他经营收益
营业利润205,364,268.63-602,862,134.87184,809,095.4455,523,080.54
利润总额205,064,249.94-630,842,405.14170,421,441.5554,981,044.42
净利润172,284,616.8-712,664,631.5176,442,914.4440,239,432.36
每股收益
其他综合收益-20,318,866.56-28,120,800.15-18,262,832.26-2,688,512.53
综合收益总额151,965,750.24-740,785,431.6658,180,082.1837,550,919.83
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计12,469,906,514.0312,024,378,519.3113,074,335,916.8713,193,620,620.77
非流动资产:
非流动资产合计16,249,413,053.1716,185,065,118.1816,219,656,664.3916,029,697,607.19
资产总计28,719,319,567.228,209,443,637.4929,293,992,581.2629,223,318,227.96
流动负债:
流动负债合计3,235,210,752.823,784,197,487.624,264,610,349.874,266,750,910.08
非流动负债:
非流动负债合计7,302,282,961.646,466,365,986.146,263,867,542.146,215,965,766.05
负债合计10,537,493,714.4610,250,563,473.7610,528,477,892.0110,482,716,676.13
所有者权益(或股东权益):
归属于母公司股东权益合计18,102,444,832.617,876,970,748.7918,522,695,742.3118,491,495,319.56
股东权益合计18,181,825,852.7417,958,880,163.7318,765,514,689.2518,740,601,551.83
负债和股东权益合计28,719,319,567.228,209,443,637.4929,293,992,581.2629,223,318,227.96
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,147,456,205.76,656,590,933.724,794,461,851.953,303,361,952.35
经营活动现金流出小计1,124,842,292.715,580,354,322.574,484,325,324.573,157,892,412.98
经营活动产生的现金流量净额22,613,912.991,076,236,611.15310,136,527.38145,469,539.37
投资活动产生的现金流量:
投资活动现金流入小计11,292,473.28195,363,461.91131,673,249.59118,794,561.48
投资活动现金流出小计254,353,190.11,543,927,390.83915,384,687.98542,039,294.86
投资活动产生的现金流量净额-243,060,716.82-1,348,563,928.92-783,711,438.39-423,244,733.38
筹资活动产生的现金流量:
筹资活动现金流入小计1,574,485,716.123,974,928,220.333,517,758,172.212,757,728,220.33
筹资活动现金流出小计1,205,223,740.693,831,504,911.893,069,863,950.872,476,865,651.66
筹资活动产生的现金流量净额369,261,975.43143,423,308.44447,894,221.34280,862,568.67
汇率变动对现金及现金等价物的影响-24,821,057.89-38,462,235.45-21,786,823.99-7,911,681.59
现金及现金等价物净增加额123,994,113.71-167,366,244.78-47,467,513.66-4,824,306.93
期末现金及现金等价物余额6,805,667,592.536,684,196,816.016,804,095,547.136,846,738,753.86
补充资料:
现金及现金等价物的净增加额--167,366,244.78--4,824,306.93
TOP↑